Cat. No.: 173 011AT488
Amount: 100 µg
Price:
$465.00
|
|
|
| Cat. No. 173 011AT488 |
100 µg purified IgG, lyophilized, fluorescence-labeled with
ATTO® 488.
Albumin and azide were added for stabilization. For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Either add 1:1 (v/v) glycerol, then aliquot and store at -20°C until use, or store aliquots at -80°C without additives. Reconstitute immediately upon receipt! Avoid bright light when working with the antibody to minimize photo bleeching of the fluorescent dye. |
| Applications | |
| Label | ATTO 488 |
| Clone | 134B1 |
| Subtype | IgG2a (κ light chain) |
| Immunogen | Full-length recombinant human GFAP (UniProt Id: P14136) |
| Epitop |
AA 391 to 405 from human GFAP (UniProt Id: P14136) |
| Reactivity |
Reacts with: human (P14136), rat (P47819), mouse (P03995), cow. No signal: zebrafish. Other species not tested yet. |
| Specificity | Specific for GFAP isoform 1 (alpha) K.O. validated |
| Matching control protein/peptide | 173-0P |
| Data sheet | 173_011at488.pdf |
|
|
Glial fibrillary acidic protein GFAP is a glial-specific member of the intermediate filament protein family. This group comprises cell type-specific filamentous proteins with similar structure and function as scaffold for cytoskeleton assembly and maintenance.
Frequently, neural stem cells also express GFAP. In addition many types of brain tumors, probably derived from astrocytic cells, heavily express GFAP. This protein is also found in the lens epithelium, Kupffer cells of the liver, in some cells in salivary tumors and others.
Point-mutations in the GFAP gene have been correlated to Alexander disease, a fatal leukoencephalopathy that leads to the dysmyelination or demyelination of the central nervous system.